Physician profile
Daniel Sharbel
NPI 1902253636
$6,429.78
in general payments reported to CMS, 2019-2025
22 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what 91% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,373 · 2020: $156 · 2021: $928 · 2022: $1,142 · 2023: $405 · 2024: $633 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,490 · Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,489.72 |
| Food and Beverage | $1,340.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,710.09 | 2025 | Matrixcombo |
| Intuitive Surgical, INC. | $1,339.09 | 2021-2023 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $612.58 | 2019 | |
| Stryker Corporation | $458.12 | 2019-2024 | Duramatrix, Vsp System, Vsp Cranial, Hydroset |
| Integra Lifesciences Corporation | $344.37 | 2019-2023 | Integra, Integra Duo, Instruments-Orthopedic |
| Glaxosmithkline, LLC. | $307.37 | 2019-2023 | Nucala |
| Kerecis Limited | $303.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kls-Martin L.P. | $203.77 | 2021 | |
| Polynovo North America LLC | $161.80 | 2023-2024 | Novosorb Btm |
| Ambu INC. | $135.33 | 2021 | |
| Medtronic, INC. | $117.22 | 2021-2025 | Stealthstation S8 Platform |
| Solventum Corporation | $114.13 | 2024 | V.A.C.Instill, V.A.C. Granufoam |
| Bolder Surgical, LLC | $113.25 | 2022 | |
| Novo Nordisk INC | $110.99 | 2020 | |
| Lilly USA, LLC | $99.84 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $87.34 | 2024-2025 | Trumatch, Matrixmidface, Matrixmandible |
| Acclarent, INC | $58.00 | 2019 | |
| Medtronic USA, INC. | $50.35 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $47.51 | 2019-2023 | Dupixent |
| Fisher & Paykel Healthcare INC | $22.76 | 2023 | Fisher & Paykel Healthcare |
| Ethicon US, LLC | $18.97 | 2023 | Echelon Flex |
| Axogen | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sharbel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.